top of page

Houston Oncology Summit: Oppenheimer analyst Jeff Jones on the growth of radiopharmaceuticals

Jeff Jones describes the science behind radiopharmaceuticals and how both new targets and better isotopes are making them more effective today.



Brought to you by:


Kommentare


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page